NEW ZEALAND BASED AI FIRM LAUNCHES TOOL TO ASSESS HEART RISK THROUGH RETINAL SCANS IN U.S.

Article source: Anastassia Gliadkovskaya, Fierce Healthcare

Toku Eyes, a New Zealand-based healthcare AI company, is launching its tool that assesses heart risk through a retinal scan in the U.S.


The tool, called ORAiCLE, uses an AI platform to identify cardiovascular threats more accurately than existing risk calculators, the company claims. The platform recognizes subtle changes in aspects like blood vessels and pigmentation to identify a person’s risk of a stroke or heart attack in the next five years.

Many Americans with diabetes are at risk of long-term complications like heart disease and blindness. Early diagnosis is critical for mitigating morbidity, but diagnosis has historically been a challenge.